August 2022

August 16, 2022
Dr. O'Dwyer and Dr. Schnall
August 16, 2022
Categories

From the Co-Chairs, August 2022

President Biden to appoint Dr. Monica Bertagnolli as NCI Director; NCI-MATCH trial data leads to FDA drug approval
Do you like it?
0 Read more
August 16, 2022
MATCH graphic
August 16, 2022
Categories

NCI-MATCH precision medicine trial leads to FDA drug approval for BRAF V600E-mutated tumors

Dabrafenib/trametinib is the first and only BRAF/MEK inhibitor combination to be approved with a tumor-agnostic indication for solid tumors carrying the BRAF V600E mutation
Do you like it?
0 Read more
August 16, 2022
Patient on PET-CT scan table
August 16, 2022
Categories

Trial Spotlight: Neha Vapiwala on the EA8191/INDICATE Study for Prostate Cancer

This phase III study is using PET/CT imaging to guide treatment for patients with post-prostatectomy biochemical recurrence
Do you like it?
0 Read more
August 16, 2022
Penn State Cancer Institute exterior photo
August 16, 2022
Categories

Institution Spotlight: Penn State Cancer Institute

A Standing Main Member of ECOG-ACRIN since 2002
Do you like it?
0 Read more
August 16, 2022
News in Brief
August 16, 2022
Categories

News in Brief, August 2022

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
Do you like it?
0 Read more